Continued changes to contact lens practice following adjustments made as a result of the COVID-19 pandemic.

Background: This study aimed to explore behaviour of practitioners in response to the COVID-19 pandemic, analysing the factors that influenced their decisions to resume professional practice post-lockdown and intention to adhere to COVID-19 protective measures.

Methods: A web-based cross-sectional survey targeting Italian practitioners was carried out to study the post lockdown behaviour and future intention to provide new contact lens (CL) fittings, and the use of protective measures. The survey also explored the dimensions of the Integrated Behavioural Model (IBM) and the Health Belief Model (HBM) to predict the intention to resume professional practice and to comply with protective measures respectively.

Development and evaluation of ocular antibiotic-loaded soluble film inserts.

Antibiotic eyedrops typically require frequent instillation due to the eye's defensive mechanisms limiting drugs from reaching target sites. This may risk patient non-adherence and treatment inefficacy. The aim of this study was to develop a biocompatible and fully soluble ocular film insert to enhance the delivery of levofloxacin, as well as the handling procedure for its administration; based on the anatomical dimensions and physiological conditions of the human eye.

BCLA CLEAR presbyopia: Management with scleral techniques, lens softening, pharmaceutical and nutritional therapies.

The aging eye undergoes the same progressive crosslinking which occurs throughout the body, resulting in increased rigidity of ocular connective tissues including the lens and the sclera which impact ocular functions. This offers the potential for a scleral treatment that is based on restoring normal biomechanical movements. Laser Scleral Microporation is a laser therapy that evaporates fractional areas of crosslinked tissues in the sclera, reducing ocular rigidity over critical anatomical zones of the accommodation apparatus, restoring the natural dynamic range of focus of the eye.

BCLA CLEAR presbyopia: Management with intraocular lenses.

Cataract surgery including intraocular lens (IOL) insertion, has been refined extensively since the first such procedure by Sir Harold Ridley in 1949. The intentional creation of monovision with IOLs using monofocal IOL designs has been reported since 1984. The first reported implantation of multifocal IOLs was published in 1987.